Hi ACExpenditure, more, in the endeavour for more/increased...

Hi AC
Expenditure, more, in the endeavour for more/increased revenue is part and parcel for this, and other ‘start up’ companies, especially the bio-health field.

Where this has fell apart, imo, is the absence of doing this in a timely manner, hence the need for past CRs, especially the last ‘two’ we weren’t suppose to have had.

Race against time; WILL significant funds/revenue hit the Admedus coffers in the immediate future or not?

Failure to do so, imo, in the immediate future will see Admedus hold out its ‘hand’ once again for funds to continue to keep ‘lights on’. 


At that time, retail interest, imo, will be nigh non-existant, thus left up to SB and SIO to mop up, even with compelling announcements I believe the retail market may have had enough of this story.


Two suitors have been and gone, (Sabby/ PFG), one would hope that both SB AND SIO continue to invest in Admedus, IF SIO were to, in the ‘unlikely’ event also ‘dump’ Admedus then that will be the end of if, imo.


Future CR will be disastrous, imo, for current and LT holders.


Sp needs to appreciate significantly in the immediate future, what will be the catalyst announcement to guarantee that in the immediate future??


For reflection; would  arrival of funds from minimum of 15, 20 mill up ......, matched with increasing revenue, without significant cash burn increases, finally create a postive market sentiment?


Currently the Admedus story is the story of death by a thousand cuts for retail holders and other parties.